Carcinoids of unknown origin: Comparative analysis with foregut, midgut, and hindgut carcinoids

被引:57
作者
Kirshbom, PM
Kherani, AR
Onaitis, MW
Feldman, JM
Tyler, DS
机构
[1] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Dept Endocrinol, Durham, NC 27710 USA
关键词
D O I
10.1067/msy.1998.93105
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Carcinoids are rare neuroendocrine tumors typically arising in the gastrointestinal tract. A significant percentage of these tumors present as metastatic disease of unknown primary site. The aim of this study was to better define the functional and clinical characteristics of carcinoids of unknown primary (CUP) site. Methods, This study examines the hormonal activity clinical characteristics, and survival of 434 patients with carcinoids originating in the foregut, midgut, hindgut, or unknown location. The 143 patients with CUP were compared with the other groups with regard to presenting characteristics, diagnostic tests and therapeutic modalities used, hormonal activity, and survival. Results. The hormone levels (urinary 5-hydroxyindoleacetic acid and serotonin, serum and platelet serotonin) of CUP were not significantly different from midgut carcinoids with metastatic disease. Although survival with CUP was shorter than with carcinoids with identified primaries (10-year survivals of 22 % vs 62 %, 50 %, and 48 % for foregut, midgut, and hindgut, respectively), the survival curve for CUP was quite similar to that of patients with midgut carcinoids with distant disease (10-year survival of 22% vs 28%). Conclusions. CUP are similar to midgut carcinoids presenting with metastatic disease with regard to hormone production and survival. Like other carcinoids, CUP can be an indolent disease process with gradual progression over decades.
引用
收藏
页码:1063 / 1070
页数:8
相关论文
共 22 条
  • [1] Anbari KK, 1997, CANCER-AM CANCER SOC, V79, P1816, DOI 10.1002/(SICI)1097-0142(19970501)79:9<1816::AID-CNCR26>3.0.CO
  • [2] 2-#
  • [3] Clinical manifestations of carcinoid disease
    Bax, NDS
    Woods, HF
    Batchelor, A
    Jennings, M
    [J]. WORLD JOURNAL OF SURGERY, 1996, 20 (02) : 142 - 146
  • [4] FELDMAN JM, 1981, CLIN CHIM ACTA, V9, P275
  • [5] GODWIN JD, 1975, CANCER, V36, P560, DOI 10.1002/1097-0142(197508)36:2<560::AID-CNCR2820360235>3.0.CO
  • [6] 2-4
  • [7] GRECO FA, 1989, SEMIN ONCOL, V16, P116
  • [8] A SIMPLE, SPECIFIC, RADIOENZYMATIC ASSAY FOR PICOGRAM QUANTITIES OF SEROTONIN OR ACETYLSEROTONIN IN BIOLOGICAL-FLUIDS AND TISSUES
    HUSSAIN, MN
    SOLE, MJ
    [J]. ANALYTICAL BIOCHEMISTRY, 1981, 111 (01) : 105 - 110
  • [9] Carcinoid tumors: Analysis of prognostic factors and survival in 301 patients from a referral center
    Janson, ET
    Holmberg, L
    Stridsberg, M
    Eriksson, B
    Theodorsson, E
    Wilander, E
    Oberg, K
    [J]. ANNALS OF ONCOLOGY, 1997, 8 (07) : 685 - 690
  • [10] KEMA IP, 1992, CLIN CHEM, V38, P534